the likelihood of relapse (i.e., odds ratios) favors the Vivitrol versus treatment as usual group broken down by gender, race, age, marital status, and other characteristics.

the likelihood of relapse (i.e., odds ratios) favors the Vivitrol versus treatment as usual group broken down by gender, race, age, marital status, and other characteristics.

May 10, 2018  | 

Friedman et al. 2018 – Patient characteristics tested to moderate (change) the effectiveness of Vivitrol